- Contraception For Teens: Let's Talk About It
- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- ASCO: Pfizer one-ups J&J with Talzenna combo's broad castration-sensitive prostate cancer win
- ASCO: With bispecifics on its heels, Incyte positions Monjuvi combo for first-line DLBCL
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
The Manhattan Institute is a respected center-right think tank best known for their City-Journal website. Chris Pope, a senior fellow at the Manhattan Institute, has written a thoughtful piece on managing skyrocketing Medicaid costs into the future:
https://thehill.com/opinion/healthcare/4022852-a-better-way-to-rein-in-medicaid/
A better way to rein in Medicaid
By Chris Pope - May 30, 2023Medicaid is two things at once: a health care benefit for poor individuals, and a system of federal grants that disproportionately profits wealthy states.
Over the past four decades, Medicaid spending has grown more than any other category of public expenditure. Republicans have tried to rein in the cost of the program with “block grants” and “per capita caps.” But these would leave states short of funds in recessions, threatening state budgets and coverage for low-income beneficiaries when assistance is most needed. As a result, Congress has repeatedly rejected these proposals — even under unified GOP control.
A better approach would be to gradually federalize responsibility for covering individuals that states must enroll in Medicaid, while leaving states to pay for whatever additional benefits they choose to provide out of their own funds.
Medicaid has been the fastest growing government program over recent years, expanding from 0.5 percent of gross domestic product in 1985 to 2.4 percent of GDP in 2022. This is partly due to the general increase in health care costs, but mostly the product of substantial expansions in eligibility. Medicare’s enrollment surged from 20 million in 1985 to 86 million in 2021 — an increase from 8 percent to 26 percent of the U.S. population.
Over that period, the expansion of Medicaid contributed to a decline from 15 percent to 11 percent in the proportion of the U.S. population that lacks health insurance. But one study estimated that for 60 percent of those newly enrolled, expansions of Medicaid coverage had simply served to displace private insurance.
Medicaid is largely structured and operated by states, with funding mostly provided by the federal government. States can claim between $1 and $9 in federal funds for every $1 they spend on the program for eligible beneficiaries, which gives them a great incentive to expand the program as much as they can. The wealthiest states with the deepest tax bases have been most able to take advantage of this arrangement: Alaska claimed $21,445 in federal Medicaid funding per resident in poverty in 2021, whereas Nevada received only $8,402. During economic expansions, states have used growing revenues to expand Medicaid, and repeatedly prodded Congress to bail them out in subsequent recessions.
For decades, congressional Republicans have sought to rein in Medicaid costs by capping federal matching aid each state can claim for each beneficiary. (This was how grants to states under the Social Security Act were all initially structured.) But this proposal has repeatedly run into a combination of substantive objections and political obstacles, which are unlikely to disappear.
Opponents have argued that capping Medicaid grants to states would threaten the funding of health care for the neediest beneficiaries. This problem would be particularly acute in recessions, when state tax revenues decline just as their Medicaid caseloads increase — exacerbating the bailout dynamic. It would also leave states in a bind if medical costs suddenly surged beyond their fiscal capacities. As proposed caps have been based on historical spending, traditionally low-spending states would have become subject to the tightest constraints. This has made per capita caps unpopular with many Republican governors as well as Democrats.
To meet these objections, the proposed caps considered (and rejected) by the Republican Congress in 2017 were so watered down that they would have been entirely ineffectual. They would have limited the growth of federal Medicaid grants to 3.7 percent per enrollee per year, even though spending had only grown at 2.0 percent per year over the previous 16 years. Nor would per enrollee caps have done anything to constrain the cost of expanding enrollment, which is the main driver of rising expenditure.
Reformers would achieve more by distributing Medicaid funds according to the needs of individuals, rather than in proportion to the resources that states are able to contribute.
To claim federal Medicaid funds, states are currently required to cover a core package of services (hospital, physician and nursing home care) for groups of mandatory beneficiaries (such as pregnant women, the disabled and children with incomes below the poverty line). They may also claim federal funds at the same matching rate to provide additional services (such as optical or dental care) and for expanding eligibility to individuals with incomes up to 380 percent of the federal poverty line.
Across the country, federal payments to states amount to 125 percent of the cost of mandatory Medicaid spending. But while federal assistance for mandatory Medicaid spending is fairly uniform across states, the wealthiest states claim several times more than the poorest in grants for optional benefits. Whereas Nevada in 2013 received federal payments covering 85 percent of the cost of benefits it was required to provide, the District of Columbia was able to claim 203 percent.
The core problem with Medicaid is the separation between control over the cost of the program (the scope of benefits, fees paid for them and the breadth of eligibility) and the responsibility for paying for it. Ideally, the federal government should directly operate and fully fund mandatory Medicaid benefits, and let states fully fund any additional benefits they choose to provide out of their own resources.
Such an arrangement would represent a big change from the status quo; thus, a more incremental reform path to get there is necessary.
To achieve this, federal payments to each state should be capped at either (1) 100 percent of the cost of providing core benefits to mandatory enrollees, or (2) the current per resident level of federal funding in nominal terms — whichever is higher. States should be allowed waivers to claim federal funds at a higher matching rate to fund mandatory spending by reducing federal aid claimed for optional spending by an equivalent amount.
This reform would focus federal Medicaid spending on the provision of core benefits for the neediest enrollees. Rather than leaving states short of funds in recessions when program costs increase, it would make the federal government largely responsible for costs resulting from increased enrollment among core eligibility groups in such circumstances.
Yet, such a reform would eliminate the incentive for states to expand the cost of Medicaid at the expense of the federal government. Over time, it would reduce real federal Medicaid spending by 20 percent, as inflation erodes the real value of grants to states where spending on optional benefits exceeds the full cost of mandatory spending. The reduction in federal spending would be limited to optional benefits and concentrated on the wealthiest states. By harmonizing benefits and reducing the disparity in assistance to states over time, this would facilitate the eventual full federalization of the program.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















